EVERPAR ADVISORS LLC

Position in ABBV — AbbVie Inc.

CIK 2010410 TULSA, OK

Position in ABBV

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,727,005

+$278,740 QoQ

Shares Held

6,863

+3.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.69%

of 13F equity value

Holder Rank

#2,087

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

EVERPAR ADVISORS LLC holds $12,411,314 across 10 Drug Manufacturers - General names. ABBV ranks #3 (13.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,780	$3,334,415
2	JNJ	Johnson & Johnson	12,152	$3,086,243
3	ABBV	AbbVie Inc. This page	6,863	$1,727,005
4	MRK	Merck & Co., Inc.	9,417	$1,210,084
5	AMGN	Amgen Inc	2,218	$803,182
6	GILD	Gilead Sciences, Inc.	4,488	$567,013
7	AZN	Astrazeneca PLC	2,894	$548,760
8	BMY	Bristol Myers Squibb Co	8,874	$511,319

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,727,005	6,863	+3.1%	Shares	Sole	2026-07-09
2026-03-31	$1,448,265	6,659	+6.0%	Shares	Sole	2026-04-21
2025-12-31	$1,435,374	6,282	+15.4%	Shares	Sole	2026-01-07
2025-09-30	$1,260,272	5,443	+12.6%	Shares	Sole	2025-10-17
2025-06-30	$897,287	4,834	+1.3%	Shares	Sole	2025-07-08
2025-03-31	$999,829	4,772	+3.5%	Shares	Sole	2025-04-16
2024-12-31	$819,019	4,609	-3.4%	Shares	Sole	2025-01-15
2024-09-30	$941,782	4,769	+1.1%	Shares	Sole	2024-10-07
2024-06-30	$809,231	4,718	+5.5%	Shares	Sole	2024-07-18
2024-03-31	$814,351	4,472	-26.8%	Shares	Sole	2024-04-22
2023-12-31	$946,401	6,107	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.